Birdwatch Note
2024-01-14 17:18:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Disease X is not an actual disease. It is a placeholder name for a hypothetical disease capable of creating an epidemic in the future. The purpose of Disease X is to improve WHO's flexibility in response to such a previously unknown pathogen. https://www.ox.ac.uk/news/2023-05-02-are-we-ethically-prepared-disease-x https://news.sky.com/story/uk-scientists-begin-work-on-defending-against-new-pandemic-caused-by-disease-x-12934956 https://www.hindustantimes.com/lifestyle/health/what-is-disease-x-can-this-potential-threat-be-deadlier-than-covid-doctor-explains-101695737927298.html
Written by BCAD941E531AD29971B8F18A87EB5A29A588AF040FE3D5B95A54EBB7017CB6D7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1746501029863047651
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1746582667225694461
- noteId - 1746582667225694461
- participantId -
- noteAuthorParticipantId - BCAD941E531AD29971B8F18A87EB5A29A588AF040FE3D5B95A54EBB7017CB6D7 Participant Details
- createdAtMillis - 1705252732461
- tweetId - 1746501029863047651
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Disease X is not an actual disease. It is a placeholder name for a hypothetical disease capable of creating an epidemic in the future. The purpose of Disease X is to improve WHO's flexibility in response to such a previously unknown pathogen. https://www.ox.ac.uk/news/2023-05-02-are-we-ethically-prepared-disease-x https://news.sky.com/story/uk-scientists-begin-work-on-defending-against-new-pandemic-caused-by-disease-x-12934956 https://www.hindustantimes.com/lifestyle/health/what-is-disease-x-can-this-potential-threat-be-deadlier-than-covid-doctor-explains-101695737927298.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-01-14 17:18:52 UTC (1705252732461) |
2024-01-15 13:51:48 UTC (1705326708001) |
CURRENTLY_RATED_HELPFUL | 2024-01-16 02:06:06 UTC (1705370766943) |
CURRENTLY_RATED_HELPFUL | 2024-01-15 13:51:48 UTC (1705326708001) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-01-15 16:03:51 -0600 | Rating Details | |
2024-01-15 15:35:30 -0600 | Rating Details | |
2024-01-15 11:32:18 -0600 | Rating Details | |
2024-01-15 10:24:03 -0600 | Rating Details | |
2024-01-15 10:14:59 -0600 | Rating Details | |
2024-01-15 03:14:55 -0600 | Rating Details | |
2024-01-15 02:26:30 -0600 | Rating Details | |
2024-01-14 19:53:13 -0600 | Rating Details | |
2024-01-14 19:08:33 -0600 | Rating Details | |
2024-01-14 18:52:36 -0600 | Rating Details | |
2024-01-14 18:07:28 -0600 | Rating Details | |
2024-01-14 17:11:45 -0600 | Rating Details | |
2024-01-14 15:00:01 -0600 | Rating Details | |
2024-01-14 14:57:05 -0600 | Rating Details | |
2024-01-14 14:54:16 -0600 | Rating Details | |
2024-01-14 14:43:27 -0600 | Rating Details | |
2024-01-14 14:38:05 -0600 | Rating Details | |
2024-01-14 14:32:38 -0600 | Rating Details | |
2024-01-14 14:13:50 -0600 | Rating Details | |
2024-01-14 13:20:31 -0600 | Rating Details | |
2024-01-14 13:17:20 -0600 | Rating Details | |
2024-01-14 13:16:57 -0600 | Rating Details | |
2024-01-14 12:40:59 -0600 | Rating Details | |
2024-01-14 12:36:45 -0600 | Rating Details | |
2024-01-14 12:27:08 -0600 | Rating Details | |
2024-01-14 12:12:34 -0600 | Rating Details | |
2024-01-14 12:01:17 -0600 | Rating Details | |
2024-01-14 11:46:35 -0600 | Rating Details | |
2024-01-14 11:28:50 -0600 | Rating Details | |
2024-01-17 19:30:57 -0600 | Rating Details | |
2024-01-17 15:04:12 -0600 | Rating Details | |
2024-01-17 20:32:04 -0600 | Rating Details | |
2024-01-18 09:51:40 -0600 | Rating Details | |
2024-01-17 22:44:03 -0600 | Rating Details | |
2024-01-17 21:14:46 -0600 | Rating Details | |
2024-01-15 19:58:16 -0600 | Rating Details | |
2024-01-15 16:47:42 -0600 | Rating Details | |
2024-01-15 06:49:39 -0600 | Rating Details | |
2024-01-15 04:51:39 -0600 | Rating Details | |
2024-01-15 03:50:27 -0600 | Rating Details | |
2024-01-14 23:45:56 -0600 | Rating Details | |
2024-01-14 21:22:29 -0600 | Rating Details | |
2024-01-14 20:39:21 -0600 | Rating Details | |
2024-01-14 19:24:34 -0600 | Rating Details | |
2024-01-14 18:43:41 -0600 | Rating Details | |
2024-01-14 18:31:51 -0600 | Rating Details | |
2024-01-14 17:57:00 -0600 | Rating Details | |
2024-01-14 15:55:00 -0600 | Rating Details | |
2024-01-14 15:45:09 -0600 | Rating Details | |
2024-01-14 15:17:56 -0600 | Rating Details | |
2024-01-14 14:59:29 -0600 | Rating Details | |
2024-01-14 14:48:09 -0600 | Rating Details | |
2024-01-14 14:35:51 -0600 | Rating Details | |
2024-01-14 14:27:10 -0600 | Rating Details | |
2024-01-14 14:18:59 -0600 | Rating Details | |
2024-01-14 14:08:00 -0600 | Rating Details | |
2024-01-14 13:56:52 -0600 | Rating Details | |
2024-01-14 13:37:56 -0600 | Rating Details | |
2024-01-14 13:18:39 -0600 | Rating Details | |
2024-01-14 13:08:08 -0600 | Rating Details | |
2024-01-14 12:42:53 -0600 | Rating Details | |
2024-01-14 12:11:22 -0600 | Rating Details | |
2024-01-14 12:03:05 -0600 | Rating Details | |
2024-01-14 11:43:59 -0600 | Rating Details | |
2024-01-14 11:38:26 -0600 | Rating Details | |
2024-01-14 11:34:44 -0600 | Rating Details |